Cytokinetics, Incorporated (CYTK)
Market Closed
1 Sep, 20:00
$
71. 40
+0.49
+0.691%
$
8.97B Market Cap
- P/E Ratio
- Div Yield
1.9M Volume
-4.45 Eps
$ 70.91
Previous Close 
Want to track CYTK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cytokinetics, Incorporated (CYTK) Statistics
Valuation metrics
Market Cap 8.97B
Enterprise value 9.99B
Trailing P/E (ttm) -10
Forward P/E -
PEG ratio 0.3
Price/Sales (ttm) 126.41
Price/Book (mrq) -54.89
Enterprise Value/Revenue 140.72
Enterprise Value/EBITDA -12.2
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.78M
Average volume (90 days) 1.96M
Price summary
52-Week low 44.91
52-Week high 88.31
Beta -
50-Day moving average 78.83
200-Day moving average 70.75
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 25 Jun 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -12.6%
Operating margin -9.93%
Operational effectiveness
Return on assets -0.46%
Return on equity 1.64%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.54
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.77
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.83
Total debt (mrq) -
Total Debt/Equity (mrq) -7.32
Current ratio (mrq) 6.66%
Book value per share (mrq) -1.31
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
